Hippocampal subregions exhibit both distinct and shared transcriptomic responses to aging and nonneurodegenerative cognitive decline

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 11, 2014, Pages 1311-1324

  Masser, Dustin R ^a   Bixler, Georgina V ^b   Brucklacher, Robert M ^b   Yan, Han ^a   Giles, Cory B ^c   Wren, Jonathan D ^c   Sonntag, William E ^a   Freeman, Willard M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Aging; Cognitive impairment; Gene expression; Hippocampus

Indexed keywords

TRANSCRIPTOME;

AGING; ANIMAL; BROWN NORWAY RAT; COGNITION; DENTATE GYRUS; FISCHER 344 RAT; GENETICS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; MALE; MAZE TEST; MEMORY; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; RAT;

AGING; ANIMALS; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; COGNITION; DENTATE GYRUS; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; RATS; RATS, INBRED BN; RATS, INBRED F344; TRANSCRIPTOME;

EID: 84911081891     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu091     Document Type: Article

References (65)

1. Hedden T, Gabrieli JD. Insights into the ageing mind: A view from cognitive neuroscience. Nat Rev Neurosci. 2004;5:87-96. doi:10.1038/ nrn1323
2. Dahle CL, Jacobs BS, Raz N. Aging, vascular risk, and cognition: Blood glucose, pulse pressure, and cognitive performance in healthy adults. Psychol Aging. 2009;24:154-162. doi:10.1037/a0014283
3. Umegaki H, Hayashi T, Nomura H, et al. Cognitive dysfunction: An emerging concept of a new diabetic complication in the elderly. Geriatr Gerontol Int. 2013;13:28-34. doi:10.1111/j.1447-0594.2012.00922.x
4. Schaie KW. Intellectual Development in Adulthood: The Seattle Longitudinal Study. Cambridge: Cambridge University Press; 1996.
5. Rapp PR, Amaral DG. Evidence for task-dependent memory dysfunction in the aged monkey. J Neurosci. 1989;9:3568-3576.
6. Rapp PR, Gallagher M. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc Natl Acad Sci USA. 1996;93:9926-9930.
7. Gower AJ, Lamberty Y. The aged mouse as a model of cognitive decline with special emphasis on studies in NMRI mice. Behav Brain Res. 1993;57:163-173.
8. Rapp PR, Deroche PS, Mao Y, Burwell RD. Neuron number in the parahippocampal region is preserved in aged rats with spatial learning deficits. Cereb Cortex. 2002;12:1171-1179.
9. Rasmussen T, Schliemann T, Sorensen JC, Zimmer J, West MJ. Memory impaired aged rats: No loss of principal hippocampal and subicular neurons. Neurobiol Aging. 1996;17:143-147.
10. Hof PR, Morrison JH. The aging brain: Morphomolecular senescence of cortical circuits. Trends Neurosci. 2004;27:607-613. doi:10.1016/j. tins.2004.07.013
11. Vanguilder HD, Freeman WM. The hippocampal neuroproteome with aging and cognitive decline: Past progress and future directions. Front Aging Neurosci. 2011;3:8. doi:10.3389/fnagi.2011.00008
12. Ownby RL. Neuroinflammation and cognitive aging. Curr Psychiatry Rep. 2010;12:39-45. doi:10.1007/s11920-009-0082-1
13. Burger C. Region-specific genetic alterations in the aging hippocampus: Implications for cognitive aging. Front Aging Neurosci. 2010;2:140. doi:10.3389/fnagi.2010.00140
14. Craft S, Foster TC, Landfield PW, Maier SF, Resnick SM, Yaffe K. Session III: Mechanisms of age-related cognitive change and targets for intervention: Inflammatory, oxidative, and metabolic processes. J Gerontol A Biol Sci Med Sci. 2012;67:754-759. doi:10.1093/gerona/ gls112
15. Kadish I, Thibault O, Blalock EM, et al. Hippocampal and cognitive aging across the lifespan: A bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment. J Neurosci. 2009;29:1805-1816. doi:10.1523/JNEUROSCI.4599-08.2009
16. Rowe WB, Blalock EM, Chen KC, et al. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci. 2007;27:3098-3110. doi:10.1523/ JNEUROSCI.4163-06.2007
17. Freeman WM, VanGuilder HD, Bennett C, Sonntag WE. Cognitive performance and age-related changes in the hippocampal proteome. Neuroscience. 2009;159:183-195. doi:10.1016/j. neuroscience.2008.12.004
18. VanGuilder HD, Farley JA, Yan H, et al. Hippocampal dysregulation of synaptic plasticity-Associated proteins with age-related cognitive decline. Neurobiol Dis. 2011;43:201-212. doi:10.1016/j.nbd.2011.03.012
19. Zeier Z, Madorsky I, Xu Y, Ogle WO, Notterpek L, Foster TC. Gene expression in the hippocampus: Regionally specific effects of aging and caloric restriction. Mech Ageing Dev. 2011;132:8-19. doi:10.1016/j. mad.2010.10.006
20. Haberman RP, Colantuoni C, Stocker AM, Schmidt AC, Pedersen JT, Gallagher M. Prominent hippocampal CA3 gene expression profile in neurocognitive aging. Neurobiol Aging. 2011;32:1678-1692. doi:10.1016/j.neurobiolaging.2009.10.005
21. VanGuilder HD, Bixler GV, Brucklacher RM, et al. Concurrent hippocampal induction of MHC II pathway components and glial activation with advanced aging is not correlated with cognitive impairment. J Neuroinflammation. 2011;8:138. doi:10.1186/1742-2094-8-138
22. Vanguilder HD, Bixler GV, Sonntag WE, Freeman WM. Hippocampal expression of myelin-Associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory. J Neurochem. 2012;121:77-98. doi:10.1111/j.1471-4159.2012.07671.x
23. VanGuilder Starkey HD, Bixler GV, Sonntag WE, Freeman WM. Expression of NgR1-Antagonizing proteins decreases with aging and cognitive decline in rat hippocampus. Cell Mol Neurobiol. 2013;33:483-488. doi:10.1007/s10571-013-9929-4
24. Newton IG, Forbes ME, Legault C, Johnson JE, Brunso-Bechtold JK, Riddle DR. Caloric restriction does not reverse aging-related changes in hippocampal BDNF. Neurobiol Aging. 2005;26:683-688.
25. VanGuilder Starkey HD, Van Kirk CA, Bixler GV, et al. Neuroglial expression of the MHCI pathway and PirB receptor is upregulated in the hippocampus with advanced aging. J Mol Neurosci. 2012;48:111-126.
26. Bixler GV, Vanguilder HD, Brucklacher RM, Kimball SR, Bronson SK, Freeman WM. Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome. BMC Med Genomics. 2011;4:40.
27. VanGuilder HD, Bixler GV, Kutzler L, et al. Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. PLoS ONE. 2011;6:e16271.
28. Krämer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30:523-530.
29. Oliveros JC. VENNY: An Interactive Tool for Comparing Lists With Venn diagrams. 2007.
30. VanGuilder Starkey HD, Sonntag WE, Freeman WM. Increased hippocampal NgR1 signaling machinery in aged rats with deficits of spatial cognition. Eur J Neurosci. 2013;37:1643-1658.
31. Zinman GE, Naiman S, Kanfi Y, Cohen H, Bar-Joseph Z. ExpressionBlast: Mining large, unstructured expression databases. Nat Methods. 2013;10:925-926. doi:10.1038/nmeth.2630
32. Lein ES, Hawrylycz MJ, Ao N, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007;445:168-176.
33. Allen Institute for Brain Science. Allen Mouse Brain Atlas. http:// mouse.brain-map.org/. Accessed December 3, 2014.
34. Lein ES, Zhao X, Gage FH. Defining a molecular atlas of the hippocampus using DNA microarrays and high-Throughput in situ hybridization. J Neurosci. 2004;24:3879-3889. doi:10.1523/ JNEUROSCI.4710-03.2004
35. Zhao X, Lein ES, He A, Smith SC, Aston C, Gage FH. Transcriptional profiling reveals strict boundaries between hippocampal subregions. J Comp Neurol. 2001;441:187-196.
36. Greene JG, Borges K, Dingledine R. Quantitative transcriptional neuroanatomy of the rat hippocampus: Evidence for wide-ranging, pathway-specific heterogeneity among three principal cell layers. Hippocampus. 2009;19:253-264. doi:10.1002/hipo.20502
37. Furukawa Y, Kawasoe T, Daigo Y, et al. Isolation of a novel human gene, ARHGAP9, encoding a rho-GTPase activating protein. Biochem Biophys Res Commun. 2001;284:643-649. doi:10.1006/ bbrc.2001.5022
38. Caronia G, Wilcoxon J, Feldman P, Grove EA. Bone morphogenetic protein signaling in the developing telencephalon controls formation of the hippocampal dentate gyrus and modifies fear-related behavior. J Neurosci. 2010;30:6291-6301. doi:10.1523/ JNEUROSCI.0550-10.2010
39. Choe Y, Kozlova A, Graf D, Pleasure SJ. Bone morphogenic protein signaling is a major determinant of dentate development. J Neurosci. 2013;33:6766-6775. doi:10.1523/JNEUROSCI.0128-13.2013
40. Bolin LM, McNeil T, Lucian LA, et al. HNMP-1: A novel hematopoietic and neural membrane protein differentially regulated in neural development and injury. J Neurosci. 1997;17:5493-5502.
41. Su D, Gudas LJ. Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells. Biochem Pharmacol. 2008;75:1129-1160. doi:10.1016/j.bcp.2007.11.006
42. Crambert G, Geering K. FXYD proteins: New tissue-specific regulators of the ubiquitous Na, K-ATPase. Sci STKE. 2003;2003:RE1. doi:10.1126/stke.2003.166.re1
43. Deng V, Matagne V, Banine F, et al. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet. 2007;16:640-650. doi:10.1093/hmg/ddm007
44. Matagne V, Budden S, Ojeda SR, Raber J. Correcting deregulated Fxyd1 expression ameliorates a behavioral impairment in a mouse model of Rett syndrome. Brain Res. 2013;1496:104-114. doi:10.1016/j.brainres.2012.12.009
45. Faivre E, Gault VA, Thorens B, Holscher C. Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis. J Neurophysiol. 2011;105:1574-1580. doi:10.1152/jn.00866.2010
46. Goldfarb M, Schoorlemmer J, Williams A, et al. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron. 2007;55:449-463. doi:10.1016/j.neuron.2007.07.006
47. Dover K, Solinas S, D'Angelo E, Goldfarb M. Long-Term inactivation particle for voltage-gated sodium channels. J Physiol (Lond). 2010;588(Pt 19):3695-3711. doi:10.1113/jphysiol.2010.192559
48. Schoorlemmer J, Goldfarb M. Fibroblast growth factor homologous factors are intracellular signaling proteins. Curr Biol. 2001;11:793-797.
49. Konig HG, Fenner BJ, Byrne JC, et al. Fibroblast growth factor homologous factor 1 interacts with NEMO to regulate NF-?B signaling in neurons. J Cell Sci. 2012;125(Pt 24):6058-6070. doi:10.1242/jcs.111880
50. Karch CM, Jeng AT, Nowotny P, Cady J, Cruchaga C, Goate AM. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains. PLoS ONE. 2012;7:e50976. doi:10.1371/ journal.pone.0050976
51. Proitsi P, Lee SH, Lunnon K, et al.; AddNeuroMed Consortium. Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood. Neurobiol Aging. 2014;35:279-290. doi:10.1016/j.neurobiolaging.2013.08.002
52. Carroll EA, Gerrelli D, Gasca S, et al. Cordon-bleu is a conserved gene involved in neural tube formation. Dev Biol. 2003;262:16-31.
53. Ahuja R, Pinyol R, Reichenbach N, et al. Cordon-bleu is an actin nucleation factor and controls neuronal morphology. Cell. 2007;131:337-350. doi:10.1016/j.cell.2007.08.030
54. Haag N, Schwintzer L, Ahuja R, et al. The actin nucleator Cobl is crucial for Purkinje cell development and works in close conjunction with the F-Actin binding protein Abp1. J Neurosci. 2012;32:17842-17856. doi:10.1523/JNEUROSCI.0843-12.2012
55. White RE, Palm C, Xu L, et al. Mice lacking the b2 adrenergic receptor have a unique genetic profile before and after focal brain ischaemia. ASN Neuro. 2012;4:AN20110020. doi:10.1042/AN20110020
56. Sim H, Hu B, Viapiano MS. Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas. J Biol Chem. 2009;284:26547-26556. doi:10.1074/jbc.M109.013185
57. Enderlin V, Pallet V, Alfos S, et al. Age-related decreases in mRNA for brain nuclear receptors and target genes are reversed by retinoic acid treatment. Neurosci Lett. 1997;229:125-129.
58. Enderlin V, Alfos S, Pallet V, et al. Aging decreases the abundance of retinoic acid (RAR) and triiodothyronine (TR) nuclear receptor mRNA in rat brain: Effect of the administration of retinoids. FEBS Lett. 1997;412:629-632.
59. Mingaud F, Mormede C, Etchamendy N, et al. Retinoid hyposignaling contributes to aging-related decline in hippocampal function in short-Term/working memory organization and long-Term declarative memory encoding in mice. J Neurosci. 2008;28:279-291. doi:10.1523/JNEUROSCI.4065-07.2008
60. Olson CR, Mello CV. Significance of vitamin A to brain function, behavior and learning. Mol Nutr Food Res. 2010;54:489-495. doi:10.1002/mnfr.200900246
61. Brossaud J, Roumes H, Moisan MP, Pallet V, Redonnet A, Corcuff JB. Retinoids and glucocorticoids target common genes in hippocampal HT22 cells. J Neurochem. 2013;125:518-531. doi:10.1111/jnc.12192
62. Kim D, Zai L, Liang P, Schaffling C, Ahlborn D, Benowitz LI. Inosine enhances axon sprouting and motor recovery after spinal cord injury. PLoS ONE. 2013;8:e81948. doi:10.1371/journal. pone.0081948
63. Dachir S, Shabashov D, Trembovler V, Alexandrovich AG, Benowitz LI, Shohami E. Inosine improves functional recovery after experimental traumatic brain injury. Brain Res. 2014;1555:78-88. doi:10.1016/j. brainres.2014.01.044
64. Muto J, Lee H, Lee H, et al. Oral administration of inosine produces antidepressant-like effects in mice. Sci Rep. 2014;4:4199. doi:10.1038/ srep04199
65. Brouillette J, Quirion R. Transthyretin: A key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging. 2008;29:1721-1732. doi:10.1016/j.neurobiolaging.2007.04.007